XIFIN is proud to participate in the UBS Genomics 2.0 and MedTech Innovation Summit. This three-day event will once again bring together key industry executives, institutional investors, and UBS professionals from across the Genomics and MedTech sectors.
The agenda will include exclusive keynote speakers and thematic panel discussions in addition to presentations from a select group of high-quality, Genomics and MedTech Innovations companies. In addition, investors will have the opportunity to speak directly with corporate executives and management team members through one-on-one and small group meetings.
XIFIN’s Chief Operating Officer, Kyle Fetter, is among the key industry executives attending the summit.